Efficacy and safety of 532-nm Q-switched Nd:YAG laser and 755-nm long pulse alexandrite laser in the treatment of solar lentigies

  • Nguyễn Trọng Hào Bệnh viện Da liễu Thành phố Hồ Chí Minh
  • Trần Nguyên Ánh Tú Bệnh viện Da liễu Thành phố Hồ Chí Minh
  • Trần Kim Phượng Bệnh viện Da liễu Thành phố Hồ Chí Minh
  • Nguyễn Duy Quân Bệnh viện Da liễu Thành phố Hồ Chí Minh

Main Article Content

Keywords

Solar lentigines, actinic lentigines, Q-switch Nd:YAG 532nm, long pulse alexandrite 755nm, efficacy, safety

Abstract

Objective: To evaluate the efficacy and safety as well as comparison between two kinds of laser in the treatment of solar lentigines. Subject and method: 35 solar lentigines were enrolled in this study, in which 22 used QS Nd:YAG 532nm and 13 used long pulse alexandrite 755nm. Each solar lentigo was received one to three session of treatment. Von-Luschan and Mexameter score were measured to evaluate the efficacy of treatment. Side effect was also noted for safety evaluation. Result: For QS Nd: YAG 532nm, Von-Luschan score and Mexameter score statistically decreased after treatment. For long pulse alexandrite, Von-Luschan score after treatment was also significantly lower than before treatment. Hyperpigmentation was note in one case using QS Nd:YAG 532nm (7.7%), erythema was showed in one case and hyperpigmentation in another case using alexandrite 755nm (9.1%). Pain score was significantly lower in patients who treated by QS Nd:YAG 532nm comparing to alexandrite 755nm. Von-Luschan evaluation after first treatment showed statistically different between two kinds of laser. Conclusion: Both QS Nd:YAG 532nm and long pulse alexandrite 755nm show efficacy and safety in the treatment of solar lentigines. QS Nd:YAG 532nm is less painful when comparing to long pulse alexandrite 755nm. QS Nd:YAG 532nm also gained earlier improvement, however, after three treatment sessions, the efficacy of two kinds of laser are similar

Article Details

References

1. Goorochurn R et al (2016) Biological processes in solar lentigo: Insights brought by experimental models. Exp Dermatol 25(3): 174-177.
2. Ortonne JP et al (2006) Treatment of solar lentigines. J Am Acad Dermatol 54(5-2): 262-271.
3. Murphy MJ and Huang MY (1994) Q-switched ruby laser treatment of benign pigmented lesions in Chinese skin. Ann Acad Med Singapore 23(1): 60-66.
4. Wang CC et al (2006) A comparison of Q-switched alexandrite laser and intense pulsed light for the treatment of freckles and lentigines in Asian persons: A randomized, physician-blinded, split-face comparative trial. J Am Acad Dermatol 54(5): 804-810.
5. Negishi K, Akita H, and Matsunaga Y (2018) Prospective study of removing solar lentigines in Asians using a novel dual-wavelength and dual-pulse width picosecond laser. Lasers Surg Med 50(8): 851-858.
6. Todd MM et al (2000) A comparison of 3 lasers and liquid nitrogen in the treatment of solar lentigines: A randomized, controlled, comparative trial. Arch Dermatol 136(7): 841-846.
7. Vachiramon V et al (2016) Comparison of Q-switched Nd:YAG laser and fractional carbon dioxide laser for the treatment of solar lentigines in Asian. Lasers Surg Med 48(4): 354-359.
8. Trafel JP et al (2007) Use of a long-pulse alexandrite laser in the treatment of superficial pigmented lesions. Dermatol Surg 33(12): 1477-1482.